| scholarly article | Q13442814 |
| P50 | author | Anthony Dorling | Q37837734 |
| P2093 | author name string | Pusey CD | |
| Lechler RI | |||
| Cook HT | |||
| Salama AD | |||
| Delikouras A | |||
| Bhangal G | |||
| P2860 | cites work | Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat | Q35604267 |
| Transplantation of discordant xenografts: a review of progress | Q37781951 | ||
| Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. | Q40849618 | ||
| In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies | Q41157257 | ||
| Protective genes expressed in endothelial cells: a regulatory response to injury | Q41632984 | ||
| Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha | Q42971426 | ||
| Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis | Q45875409 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Long-term survival of hamster-to-rat cardiac xenografts in the absence of a Th2 shift | Q47842710 | ||
| In vitro accommodation of porcine endothelial cells by low dose human anti-pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production. | Q54113471 | ||
| Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients | Q68196123 | ||
| Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation | Q69366948 | ||
| Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells | Q70067993 | ||
| Renal transplantation following immunoadsorption in highly sensitized recipients | Q70665171 | ||
| Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity | Q71615073 | ||
| Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients | Q71983558 | ||
| Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment | Q73034296 | ||
| Antibody-mediated rejection of human renal allografts: an electron microscopic study of peritubular capillaries | Q73416407 | ||
| Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes | Q77658697 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 260-269 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. | |
| P478 | volume | 1 |
| Q53639822 | A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. |
| Q58836893 | A pig allograft model of antibody-mediated rejection |
| Q35607565 | ABO Incompatible Kidney Transplantation-Current Status and Uncertainties |
| Q44512119 | Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury |
| Q37445163 | Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts |
| Q37904197 | Antibody-mediated allograft rejection: the emerging role of endothelial cell signalling and transcription factors. |
| Q36263023 | Antibody-mediated organ-allograft rejection |
| Q82659907 | C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation |
| Q38002449 | Cardiac antibody-mediated rejection |
| Q36379451 | Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation |
| Q37058050 | Chronic alloantibody mediated rejection |
| Q84238174 | Chronic rejection of human kidney allografts |
| Q35788603 | Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches |
| Q39718995 | Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates |
| Q38226479 | Complement modulation in solid-organ transplantation. |
| Q40359260 | Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance |
| Q98727034 | Current protocols and outcomes of ABO-incompatible kidney transplantation |
| Q40749159 | Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection. |
| Q35554487 | Diagnosis and treatment of antibody-mediated kidney allograft rejection |
| Q40815282 | Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations |
| Q35547335 | Effect of antibodies on endothelium |
| Q35124576 | Emerging role of B cells in chronic allograft dysfunction |
| Q37642331 | Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. |
| Q35724702 | Feasibility of xeno-transplantation |
| Q34466691 | Gene expression patterns in lung rejection |
| Q38216381 | Graft microvascular disease in solid organ transplantation |
| Q46907583 | HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway |
| Q36360674 | HLA class I: an unexpected role in integrin β4 signaling in endothelial cells |
| Q37596125 | Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways |
| Q53060554 | Increased intragraft rejection-associated gene transcripts in patients with donor-specific antibodies and normal biopsies. |
| Q30422315 | Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model |
| Q38172280 | Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation |
| Q73041731 | Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis |
| Q39197753 | Over-expression of heme oxygenase-1 does not protect porcine endothelial cells from human xenoantibodies and complement-mediated lysis |
| Q33888812 | Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations |
| Q44630596 | Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. |
| Q27027106 | Plasmapheresis in immunologic renal disease |
| Q37414657 | Report from a consensus conference on the sensitized patient awaiting heart transplantation |
| Q38289602 | Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation |
| Q37710374 | Sensitized renal transplant recipients: current protocols and future directions |
| Q35140893 | Significance of endothelial cell survival programs for renal transplantation |
| Q46216270 | Successful living related kidney transplantation across an anti-donor HLA antibody |
| Q43805381 | The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome |
| Q35223952 | The link between major histocompatibility complex antibodies and cell proliferation |
| Q38013049 | The role of complement in the early immune response to transplantation. |
| Q58836908 | Transplant Accommodation |
| Q37952349 | Transplant accommodation--are the lessons learned from xenotransplantation pertinent for clinical allotransplantation? |
| Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
| Q27024077 | Vascular endothelium as a target of immune response in renal transplant rejection |
| Q43982164 | Vienna experience of ABO-incompatible living-donor kidney transplantation |
| Q79979170 | [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions] |
Search more.